• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌患者肠道微生物组的变化:基于 16S 基因测序技术的系统评价和荟萃分析。

Changes in the gut microbiome of patients with esophageal cancer: A systematic review and meta-analysis based on 16S gene sequencing technology.

机构信息

The Affiliated Hospital, Southwest Medical University, Luzhou 611630, China; Department of General Medicine, General Hospital of PLA Western Theater Command, Chengdu 610083, China.

Department of Nursing, Nursing School, Chengdu Medical College, Chengdu 610083, China.

出版信息

Microb Pathog. 2024 Aug;193:106784. doi: 10.1016/j.micpath.2024.106784. Epub 2024 Jul 4.

DOI:10.1016/j.micpath.2024.106784
PMID:38971508
Abstract

BACKGROUND

Esophageal cancer (EC) possesses a high degree of malignancy and exhibits poor therapeutic outcomes and prognosis. However, its pathogenesis remains unclear. With the development of macrogene sequencing technology, changes in the intestinal flora have been found to be highly related to the development of EC, although discrepancies and controversies remain in this research area.

MATERIALS AND METHODS

We comprehensively searched the PubMed, EMBASE, and Cochrane's Central Controlled Trials Register and the Scientific Network's database search projects based on systematically reviewed preferred reporting projects and meta-analyses. We used Engauge Digitizer for data extraction and Stata 15.1 for data analysis. In addition, we used the Newcastle-Ottawa Scale for grade grading and forest and funnel plots, sensitivity, and Egger and Beggar tests to evaluate the risk of bias.

RESULTS

This study included 10 studies that assessed stool, tumor, and nontumor esophageal mucosa (gastroscopy and surgical resection) samples from 527 individuals, including 273 patients with EC and 254 healthy control group. We observed remarkable differences in microbial diversity in EC patients compared to healthy controls. The Chao1 index (46.01 vs. 42.67) was significantly increased in EC patients, whereas the Shannon index (14.90 vs. 19.05), ACE (39.24 vs. 58.47), and OTUs(28.93 vs. 70.10) were significantly lower. At the phylum level, the abundance of Bacteroidetes (37.89 vs. 32.77) increased significantly, whereas that of Firmicutes (37.63 vs. 38.72) decreased significantly; the abundance of Clostridium and Verruciformis increased, while that of Actinobacteria and Proteobacteria decreased to varying degrees. The abundance of Bacteroides (8.60 vs. 15.10) and Streptococcaceae (15.08 vs. 27.05) significantly reduced in EC.

CONCLUSIONS

According to our meta-analysis, in patients with EC, the Chao1 index increased, whereas the Shannon and the OTUs decreased. At the phylum level, the abundance of Firmicutes decreased significantly, whereas that of Bacteroidetes and Proteobacteria increased significantly. At the genus/family level, the abundance of Bacteroidaceae, Prevotellaceae and Streptococcaceae decreased significantly, whereas that of Veillonellaceae increased. This meta-analysis identified changes in gut microbiota in patients with EC; however, its conclusions were inconsistent.

摘要

背景

食管癌(EC)恶性程度高,治疗效果和预后差。但其发病机制尚不清楚。随着宏基因组测序技术的发展,肠道菌群的变化与 EC 的发生发展密切相关,但该研究领域仍存在差异和争议。

材料与方法

我们全面检索了 PubMed、EMBASE 和 Cochrane 中央对照试验登记处以及科学网络数据库搜索项目,基于系统综述的首选报告项目和荟萃分析进行检索。我们使用 Engauge Digitizer 进行数据提取,使用 Stata 15.1 进行数据分析。此外,我们使用纽卡斯尔-渥太华量表进行分级评分,使用森林图和漏斗图、敏感性、Egger 和 Beggar 检验评估偏倚风险。

结果

本研究纳入了 10 项研究,评估了 527 名个体的粪便、肿瘤和非肿瘤食管黏膜(胃镜和手术切除)样本,包括 273 名 EC 患者和 254 名健康对照组。我们观察到 EC 患者的微生物多样性与健康对照组有显著差异。Chao1 指数(46.01 比 42.67)在 EC 患者中显著增加,而 Shannon 指数(14.90 比 19.05)、ACE(39.24 比 58.47)和 OTUs(28.93 比 70.10)显著降低。在门水平上,厚壁菌门(37.89 比 32.77)的丰度显著增加,而拟杆菌门(37.63 比 38.72)的丰度显著降低;梭菌属和疣微菌属的丰度增加,而放线菌门和变形菌门的丰度则不同程度地降低。Bacteroides(8.60 比 15.10)和 Streptococcaceae(15.08 比 27.05)在 EC 中的丰度显著降低。

结论

根据我们的荟萃分析,在 EC 患者中,Chao1 指数增加,而 Shannon 和 OTUs 减少。在门水平上,厚壁菌门的丰度显著降低,而拟杆菌门和变形菌门的丰度显著增加。在属/科水平上,拟杆菌科、普雷沃氏菌科和链球菌科的丰度显著降低,而韦荣球菌科的丰度增加。本荟萃分析确定了 EC 患者肠道微生物群的变化,但结论不一致。

相似文献

1
Changes in the gut microbiome of patients with esophageal cancer: A systematic review and meta-analysis based on 16S gene sequencing technology.食管癌患者肠道微生物组的变化:基于 16S 基因测序技术的系统评价和荟萃分析。
Microb Pathog. 2024 Aug;193:106784. doi: 10.1016/j.micpath.2024.106784. Epub 2024 Jul 4.
2
Gut microbiota alterations in colorectal adenoma-carcinoma sequence based on 16S rRNA gene sequencing: A systematic review and meta-analysis.基于 16S rRNA 基因测序的结直肠腺瘤-癌序列中肠道微生物组的改变:系统评价和荟萃分析。
Microb Pathog. 2024 Oct;195:106889. doi: 10.1016/j.micpath.2024.106889. Epub 2024 Aug 26.
3
[Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].[16S核糖体RNA高通量测序技术分析特重度烧伤患者肠道微生物群的动态变化]
Zhonghua Shao Shang Za Zhi. 2020 Dec 20;36(12):1159-1166. doi: 10.3760/cma.j.cn501120-20200518-00271.
4
Gut Microbiota Profile in Patients with Type 1 Diabetes Based on 16S rRNA Gene Sequencing: A Systematic Review.基于 16S rRNA 基因测序的 1 型糖尿病患者肠道微生物群特征:系统评价。
Dis Markers. 2020 Aug 27;2020:3936247. doi: 10.1155/2020/3936247. eCollection 2020.
5
Dysbiosis of gut microbiota in patients with esophageal cancer.食管癌患者肠道微生物失调。
Microb Pathog. 2021 Jan;150:104709. doi: 10.1016/j.micpath.2020.104709. Epub 2020 Dec 27.
6
Changes in the gut microbiota of osteoporosis patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.基于 16S rRNA 基因测序的骨质疏松症患者肠道微生物组变化:系统评价和荟萃分析。
J Zhejiang Univ Sci B. 2022 Dec 15;23(12):1002-1013. doi: 10.1631/jzus.B2200344.
7
Changes in the gut microbiota of esophageal carcinoma patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.基于16S rRNA基因测序的食管癌患者肠道微生物群变化:系统评价与荟萃分析
Front Oncol. 2024 Aug 29;14:1366975. doi: 10.3389/fonc.2024.1366975. eCollection 2024.
8
Alteration of the gut microbiome in patients with heart failure: A systematic review and meta-analysis.心力衰竭患者肠道微生物组的改变:系统评价和荟萃分析。
Microb Pathog. 2024 Jul;192:106647. doi: 10.1016/j.micpath.2024.106647. Epub 2024 May 23.
9
Changes in the fecal microbiota of breast cancer patients based on 16S rRNA gene sequencing: a systematic review and meta-analysis.基于 16S rRNA 基因测序的乳腺癌患者粪便微生物组变化:系统评价和荟萃分析。
Clin Transl Oncol. 2024 Jun;26(6):1480-1496. doi: 10.1007/s12094-023-03373-5. Epub 2024 Jan 13.
10
Gut microbial dysbiosis and its association with esophageal cancer.肠道微生物失调及其与食管癌的关系。
J Appl Biomed. 2021 Mar;19(1):1-13. doi: 10.32725/jab.2021.005. Epub 2021 Feb 3.

引用本文的文献

1
Timing and Protocols for Microbiome Intervention in Surgical Patients: A Literature Review of Current Evidence.外科患者微生物群干预的时机与方案:当前证据的文献综述
Cureus. 2025 Jun 15;17(6):e86104. doi: 10.7759/cureus.86104. eCollection 2025 Jun.
2
Splenic volume as a predictor of survival in cancer patients treated with immune checkpoint inhibitors.脾脏体积作为接受免疫检查点抑制剂治疗的癌症患者生存的预测指标。
Front Immunol. 2025 May 30;16:1598484. doi: 10.3389/fimmu.2025.1598484. eCollection 2025.
3
Prognostic value of body adipose tissue parameters in cancer patients treated with immune checkpoint inhibitors.
免疫检查点抑制剂治疗的癌症患者体内脂肪组织参数的预后价值
Front Immunol. 2025 Feb 12;16:1557726. doi: 10.3389/fimmu.2025.1557726. eCollection 2025.
4
From microbes to medicine: harnessing the power of the microbiome in esophageal cancer.从微生物到医学:利用微生物组在食管癌中的作用。
Front Immunol. 2024 Nov 12;15:1450927. doi: 10.3389/fimmu.2024.1450927. eCollection 2024.